| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/14/2005 | WO2005063807A2 Treatment of coronary or peripheral ischemia |
| 07/14/2005 | WO2005063806A1 Arginine hydrochloride enhances chaperone-like activity of alpha crystallin |
| 07/14/2005 | WO2005063801A2 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 07/14/2005 | WO2005063799A2 Peptide synthesis and deprotection with co-solvent |
| 07/14/2005 | WO2005063796A1 Inhibitors of amyloid precursor protein processing |
| 07/14/2005 | WO2005063795A1 Glutathione derivatives and their uses for the treatment of viral diseases |
| 07/14/2005 | WO2005063302A1 Drug for preventing or treating heart diseases comprising cd9 gene |
| 07/14/2005 | WO2005063301A1 Emt inducer |
| 07/14/2005 | WO2005063298A1 Stable growth hormone liquid formulation |
| 07/14/2005 | WO2005063290A2 Use of il-18 binding protein in inflammations |
| 07/14/2005 | WO2005063279A1 Means for stimulation and activation of hair growth by il-15 |
| 07/14/2005 | WO2005063278A1 Surface protection of exposed biological tissues |
| 07/14/2005 | WO2005063277A1 18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites, and method for the production thereof |
| 07/14/2005 | WO2005063276A1 Methods and compositions using gonadotropin hormone releasing hormone |
| 07/14/2005 | WO2005063275A1 Methods and compositions for the prevention and treatment of inflammatory diseases or conditions |
| 07/14/2005 | WO2005063242A1 Use of macrolides for treating or preventing airflow obstruction |
| 07/14/2005 | WO2005063226A1 Compositions and methods for treating diabetes |
| 07/14/2005 | WO2005063202A2 Method for preparing solid dosage form of desmopressin |
| 07/14/2005 | WO2005063184A1 Methods and compositions for oral hygiene |
| 07/14/2005 | WO2005063156A1 Oral peptide delivery system with improved bioavailability |
| 07/14/2005 | WO2005062918A2 Methods of treating asthma |
| 07/14/2005 | WO2005062874A2 Compounds and compositions for delivering active agents |
| 07/14/2005 | WO2005056043A3 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 07/14/2005 | WO2005049066A3 Use of dudulin2 for the treatment or prophylaxis of lung cancer |
| 07/14/2005 | WO2005045038A8 RNA INTERFERENCE MEDIATED INHIBITION OF GPRA AND AAA1 GENE EXPRESSION USING SHORT NUCLEIC ACID (siNA) |
| 07/14/2005 | WO2005044188A3 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent |
| 07/14/2005 | WO2005040142B1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/14/2005 | WO2005039614A3 Omega interferon for the treatment of hiv/aids, cancer and human and veterinary asthma |
| 07/14/2005 | WO2005021494A9 D-amino acid peptides |
| 07/14/2005 | WO2005014822A3 Novel therapeutic fusion proteins |
| 07/14/2005 | WO2005012350A3 Epha2 t-cell epitope agonists and uses therefor |
| 07/14/2005 | WO2005011689A3 Treatment of inflamed joints |
| 07/14/2005 | WO2005007675A3 TRIAZOLE ϵ-AMINO ACIDS |
| 07/14/2005 | WO2005007118A3 Treatment or prevention of damage due to radiation exposure |
| 07/14/2005 | WO2005006890A3 Foods, beverages, condiments, spices and salad dressings with specialized supplements |
| 07/14/2005 | WO2005002508A3 Macromolecular platinum chelates |
| 07/14/2005 | WO2005000871A3 Peptides antagonistic to an anti-angiogenic antibody and uses therefor |
| 07/14/2005 | WO2004111084A3 Peptides enhancing ceh activity or inhibiting acat activity, pharmaceutical compositions comprising these peptides and their use in the treatment of atherosclerosis |
| 07/14/2005 | WO2004108765A3 Extracellular aspergillus polypeptides |
| 07/14/2005 | WO2004103394A3 Method and compositions for nerve regeneration |
| 07/14/2005 | WO2004101747A3 Identification and use of gpr54 and its ligands for reproductive disorders and contraception |
| 07/14/2005 | WO2004060270A8 Compositions and methods for the diagnosis and treatment of tumor |
| 07/14/2005 | WO2004020969A3 Production of nanoparticles having a defined number of ligands |
| 07/14/2005 | WO2004017923A3 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 07/14/2005 | WO2003082212A3 Method for treating cancer in humans |
| 07/14/2005 | WO2003029424A3 Novel proteins and nucleic acids encoding same |
| 07/14/2005 | WO2002072793A3 Expression of properly folded and soluble extracellular domain of a gonadotropin receptor |
| 07/14/2005 | US20050155096 Expression vector comprising nucleotide sequences granulocyte colony stimulating factor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/14/2005 | US20050155089 Transport protein for use in identifying modulators for prevention and treatment of inflammation, cardiovascular, neurological, reproductive and developmental disorders |
| 07/14/2005 | US20050154454 Intravascular devices and fibrosis-inducing agents |
| 07/14/2005 | US20050154453 Intravascular devices and fibrosis-inducing agents |
| 07/14/2005 | US20050154445 Intravascular devices and fibrosis-inducing agents |
| 07/14/2005 | US20050154374 Implantable sensors and implantable pumps and anti-scarring agents |
| 07/14/2005 | US20050154229 Salt formation from the free base and maleic acid in the presence of an alcohol solvent to obtain the amorphous salt form, and then recrystallization; thrombin inhibitors with optimal solubility and no deliquescence |
| 07/14/2005 | US20050154193 Immunoglobulin for use in diagnosis, prevention and treatment of infection, neurodegenerative, inflammatory and autoimmune disorders; immunotherapy |
| 07/14/2005 | US20050154189 Receptor polypeptide for use as immunomodulator in enhancement of immune response; immunotherapy |
| 07/14/2005 | US20050154188 Cytoplasmic tranduction peptides and uses thereof |
| 07/14/2005 | US20050154187 Especially fused to dihydrofolate reductase, used for treating diseases marked by increased angiogenesis; also polynucleotides encoding the polypeptide and use of the polynucleotides in gene therapy. |
| 07/14/2005 | US20050154165 Ph-sensitive polymer |
| 07/14/2005 | US20050154040 Nitrogen-containing heteroaryl derivatives |
| 07/14/2005 | US20050153952 Methods for inhibiting sterol absorption |
| 07/14/2005 | US20050153947 administering mixture of serotonine reuptake inhibitor and corticosteroid |
| 07/14/2005 | US20050153934 Chaperone-based therapy for Niemann-Pick disease |
| 07/14/2005 | US20050153924 Antisense modulation of interferon gamma receptor 2 |
| 07/14/2005 | US20050153922 MutS homolog 5 (MSH5); gene expression inhibition; for modulation of fertility |
| 07/14/2005 | US20050153921 Methods of using mammalian RNase H and compositions thereof |
| 07/14/2005 | US20050153919 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 07/14/2005 | US20050153918 Purified short interference RNA; for neoplastic treatment; kits |
| 07/14/2005 | US20050153917 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 07/14/2005 | US20050153916 Each strand of the siNA molecule is 18 to 23 nucleotides in length; and one strand comprises a nucleotide sequence having sufficient complementarity to telomerase RNA for the siNA molecule to direct cleavage of the RNA via RNA interference. |
| 07/14/2005 | US20050153915 RNA interference mediated inhibition of early growth response gene expression using short interfering nucleic acid (siNA) |
| 07/14/2005 | US20050153914 RNA interference mediated inhibition of MDR P-glycoprotein gene expression using short interfering nucleic acid (siNA) |
| 07/14/2005 | US20050153912 Antiviral oligonucleotides targeting viral families |
| 07/14/2005 | US20050153911 Antisense modulation of extracellular-signal-regulated kinase-6 expression |
| 07/14/2005 | US20050153909 Producing a cell that contains heterologous nucleic acid byintroducing a satellite artificial chromosome (SATAC) into the cell |
| 07/14/2005 | US20050153906 Such as Hurler syndrome and Batten by administering an aminoglycosidesuch as gentamicin, G418, hygromycin B, paromomycin, tobramycin, lividomycin A, amikacin, sisomycin, or neomycin, optionally in combination with an enzyme effective for enzyme replacement therapy, a polyionic compound or gene therapy |
| 07/14/2005 | US20050153903 Inhibitors of enzymes for treatment of Aids or making intermediates |
| 07/14/2005 | US20050153901 Of EtO2C CH2 (R)Cgl-Aze-Pab-OH or its salt; high chemical and solid state stability; thrombin inhibitors |
| 07/14/2005 | US20050153900 Novel inhibitors of hepatitis C virus NS3/NS4a serine protease |
| 07/14/2005 | US20050153899 administering an initial dose of pegvisomant to the patients with acromegaly, at week 4 after the final dose of the octreotide long-acting release (LAR) formulation is administered; side effect reduction |
| 07/14/2005 | US20050153898 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 07/14/2005 | US20050153897 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 07/14/2005 | US20050153896 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 07/14/2005 | US20050153895 Laminin polypeptide biodrugs; inhibitors of A beta fibril formation and growth in brain |
| 07/14/2005 | US20050153894 capable of inhibiting cyclin dependent kinases (CDK) or cyclin complexes, used in the treatment of proliferative disorders such as cancers and leukemias |
| 07/14/2005 | US20050153892 Compound B as an angiogenic agent in combination with human growth factors |
| 07/14/2005 | US20050153891 proteins coded by murine herpes viruses, or homologues, use in binding chemokines, to produce an immunomodulatory or antiinflammatory effects |
| 07/14/2005 | US20050153890 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2005 | US20050153889 Modulation of pericyte proliferation |
| 07/14/2005 | US20050153888 oligopeptides capable of stimulating the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM), used for treatment of normal, degenerated and damaged NCAM presenting cells |
| 07/14/2005 | US20050153887 Compositions for inducing cell growth and differentiation and methods of using same |
| 07/14/2005 | US20050153886 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 07/14/2005 | US20050153884 Methods of therapy with thrombin derived peptides |
| 07/14/2005 | US20050153883 Composition for stimulating de novo bone induction |
| 07/14/2005 | US20050153882 Polypeptides as angiogenesis inhibitors |
| 07/14/2005 | US20050153881 Produced by a lactic acid producing bacterial strain having the identifying characteristics of a strain selected from NRRL B-30514, NRRL B-30510, NRRL B-30511, and NRRL B-30645; used for reducing levels of colonization by a target bacteria in animals, especially poultry |
| 07/14/2005 | US20050153880 prophylaxis of inflammatory bowel disease (IBD), including, Crohn's disease and gastrointestinal disorders caused by bacteria, ischemia, radiation, drugs or chemical substances; comprising, administering an interleukin (IL-18) polypeptide or fragments; interferons; cytokines |
| 07/14/2005 | US20050153879 Process for the preparation of a desired erythropoietin glyco-isoform profile |
| 07/14/2005 | US20050153878 Fgfr agonists |
| 07/14/2005 | US20050153877 Macrocyclic hepatitis C serine protease inhibitors |